Medication management for left ventricular assist device thrombosis.

@article{Hohner2015MedicationMF,
  title={Medication management for left ventricular assist device thrombosis.},
  author={Elizabeth M. Hohner and Jessica R Crow and Michael P Moranville},
  journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  year={2015},
  volume={72 13},
  pages={1104-13}
}
PURPOSE Current strategies for prevention and treatment of "pump thrombosis" associated with the use of left ventricular assist devices (LVADs) are discussed. SUMMARY LVADs provide morbidity, mortality, and quality-of-life benefits in patients with advanced heart failure. Since continuous-flow LVADs came into wide use, there have been increased reports of pump thrombosis (clot formation in the LVAD system that can lead to pump dysfunction and clinical complications). Anticoagulation and… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 20 times over the past 90 days. VIEW TWEETS